A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The primary objective of this study was to compare the change in intraocular pressure (IOP) of three different doses of latanoprost (75, 100 and 125 ug/ml) to that of the marketed 50 ug/ml dose, in a dose ranging study.
Epistemonikos ID: 1d5674b4fc20aafa915227c05ac83bde0aec84a6
First added on: May 06, 2024